Acct 352 research case | Accounting homework help

 Background Advanced Chemical Industries (ACI) is a leading pharmaceutical company. ACI only operates in the US. Excluding the deferred tax asset, ACI total assets are $3.5 million. ACI was a profitable company. In 2018, ACI began reporting a net loss (both book and tax loss), which has been primarily attributable to significant research and development costs. Now it is 2020. The following table presents the loss figures for ACI. ACI’s relevant statutory tax rate is 21% and the company did not have any permanent book-tax differences during 2018, 2019 or 2020. ACI did not establish a valuation allowance to offset the deferred tax asset in 2018 or 2019. 2018 2019 2020 Pretax book loss $ (900,000) $(1,890,000) $(775,000) Net temporary differences (210,000) (60,000) (110,000) Taxable loss (1,110,000) (1,950,000) (885,000) Statutory tax rate 21% 21% 21% Impact on the deferred tax asset balance 233,100 409,500 185,850 Net loss (after tax)* $(666,900) $(1,480,500) $(589,150) Deferred tax asset balance $233,100 $642,600 $828,450 Valuation allowance* – – ? ACI is assessing the need to record a valuation allowance to offset the deferred tax asset balance created by the net operating loss carryforward. While the company has reported losses in the past three years, management anticipates positive income in the future. The executives of ACI do not anticipate any fundamental shift in its business operations in the future. The company is currently in the final research and development stage of a new drug that has tremendous market opportunity. Management believes that this drug will be on the market within three years based on the company’s past experience. The income projections for the next five years prepared by the CFO are presented below. The CFO determined that, while NOL can be carried forward indefinitely, predicting numbers beyond the 5- year period was impractical. However, the CFO does anticipate positive taxable income in 2026 and beyond, because the new drug can bring long-term profit and there lacks of any known competing drugs. The CFO has been with ACI for his entire career and has been extremely competent in terms of preparing income projections and meeting forecasts. The income effect of the new drug is based on information gathered when its most recent significant drug was released. There have been no actual or expected changes in tax laws indicating a potential change in the statutory tax rate. The projections provided have been shared with analysts and investors.  The CFO obtained a schedule for the existing taxable temporary differences relating to the gross deferred tax liability at December 31, 2020. This schedule was reviewed by the tax director. The schedule indicated that there would be no reversals scheduled in the foreseeable future. 2021 2022 2023 2024 2025 Pretax book loss, excluding new drug $(750,000) $(600,000) $ (525,000) $ (490,000) $ (350,000) Income effect of new drug 2,000,000 3,500,000 3,750,000 Pretax book (loss) income (750,000) (600,000) 1,475,000 3,010,000 3,400,000 Net temporary differences (110,000) (110,000) (110,000) (110,000) (150,000) Future taxable (loss) income (860,000) (710,000) 1,365,000 2,900,000 3,250,000 Limitation on carryforwards 80% 80% 80% Future taxable income available to offset carryforward 1,092,000 2,320,000 2,600,000* Statutory tax rate 21% 21% 21% 21% 21% Impact on deferred tax asset balance 180,600 149,100 (229,320) (487,200) (441,630)* Beginning of year deferred tax asset balance 828,450 1,009,050 1,158,150 928,830 441,630 End of year deferred tax asset balance $1,009,050 $1,158,150 $ 928,830 $ 441,630 $ – *For 2025, there is only $441,630 left in the deferred tax asset account balance As the junior accountant, the CFO has asked you to provide him with an analysis of the need for a valuation allowance account for the deferred tax asset. The CFO has informed you that the tax director has said that ACI does not have any available tax-planning strategies to realize the deferred tax asset. The CFO has suggested that beyond looking at ASC 740 for guidance on this determination, she also recommends that you read paragraphs 99 through 103 in the Basis for Conclusions in SFAS No. 109. Required For December 31, 2020, using your judgment, perform an analysis of the need for a valuation allowance to offset part, or all, of the deferred tax asset created by the net operating loss carryforward. Document your judgment in a draft memorandum format that you will provide to the CFO (not to exceed 2-3 pages, double space, 12 font size). Always include references to the applicable guidance. Upon completing your documentation, make certain that you are able to address the following considerations: – Is the documentation sufficient to support your judgment? Specially, regarding the size of the valuation allowance, why possible alternatives were not selected? – Can another professional, possibly outside of the accounting field, understand what you are trying to say, as well as how you reached your conclusion? 

Calculate the price of your order

Select your paper details and see how much our professional writing services will cost.

We`ll send you the first draft for approval by at
Price: $36
  • Freebies
  • Format
  • Formatting (MLA, APA, Chicago, custom, etc.)
  • Title page & bibliography
  • 24/7 customer support
  • Amendments to your paper when they are needed
  • Chat with your writer
  • 275 word/double-spaced page
  • 12 point Arial/Times New Roman
  • Double, single, and custom spacing
  • We care about originality

    Our custom human-written papers from top essay writers are always free from plagiarism.

  • We protect your privacy

    Your data and payment info stay secured every time you get our help from an essay writer.

  • You control your money

    Your money is safe with us. If your plans change, you can get it sent back to your card.

How it works

  1. 1
    You give us the details
    Complete a brief order form to tell us what kind of paper you need.
  2. 2
    We find you a top writer
    One of the best experts in your discipline starts working on your essay.
  3. 3
    You get the paper done
    Enjoy writing that meets your demands and high academic standards!

Samples from our advanced writers

Check out some essay pieces from our best essay writers before your place an order. They will help you better understand what our service can do for you.

Get your own paper from top experts

Order now

Perks of our essay writing service

We offer more than just hand-crafted papers customized for you. Here are more of our greatest perks.

  • Swift delivery
    Our writing service can deliver your short and urgent papers in just 4 hours!
  • Professional touch
    We find you a pro writer who knows all the ins and outs of your subject.
  • Easy order placing/tracking
    Create a new order and check on its progress at any time in your dashboard.
  • Help with any kind of paper
    Need a PhD thesis, research project, or a two-page essay? For you, we can do it all.
  • Experts in 80+ subjects
    Our pro writers can help you with anything, from nursing to business studies.
  • Calculations and code
    We also do math, write code, and solve problems in 30+ STEM disciplines.

Frequently asked questions

Get instant answers to the questions that students ask most often.

See full FAQ
    See full FAQ

    Take your studies to the next level with our experienced specialists

    Hello, we are online 24/7. Leave a message we will reply instantly